Jeff Krajewski is a Senior Research Advisor at Eli Lilly and Company. He possess expertise in drug discovery, assay development, high throughput screening, biotechnology, cell culture and 3 more skills. Colleagues describe him as "I had the pleasure of working with Jeff as part of the Icagen/Pfizer collaboration to identify new ion channel modulators for the treatment of pain. Jeff is an expert electrophysiologist with a constant enthusiasm for his science. Despite the intense pressure on the project, Jeff remained cool and continually delivered high quality results. His inquisitive nature led to unprecedented discoveries which were incredibly useful, and in turn sparked new ideas. Jeff is a fantastic scientist to work with, and I hope our paths will cross again in the future."